Press "Enter" to skip to content

Pfizer vaccine ‘highly effective’ in reducing coronavirus transmission, study suggests

The Covid-19 vaccine developed by Pfizer and BioNTech appears to be highly effective in limiting the spread of the virus, according to reported data from Israel, in a development that could alter the course of the pandemic.

A study conducted by Pfizer and the Israeli Health Ministry shows that the vaccine is 89.4 per cent effective at preventing infections, whether symptomatic or not.

The results have not yet been publicly released or peer reviewed but come from a draft publication that was obtained by Ynet, an Israeli newspaper, and have also been confirmed by Bloomberg, the Financial Times and Der Spiegel.

The findings, taken from Israel’s ongoing vaccine rollout, provide the first real-world indication that transmission of the virus is likely to be curbed through immunisation.

Previous data from Israel and elsewhere have already shown that the Covid-19 vaccines are effective in preventing serious disease, admittance to hospital and death from the virus.

But a reduction in the spread of Sars-CoV-2 – the virus that causes Covid-19 – offers hope that the acute phase of the pandemic can be brought to an end by the summer.

Israel is leading the way with its inoculation programme, having delivered at least one dose of the Pfizer/BioNTech jab to nearly half of its population. Read from source….